Score Overview
Explore the 2021 public Archive ranking →
Where Achieve Life Sciences Inc has ranked, year by year
Showing 1 year ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- ACHV
2001: 99.8% · 2018: 59.5% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-30 | $ 8.09 | — |
1 Year2025-09-30 | $ 3.15 | 156.83% |
5 Years2021-09-30 | $ 8.50 | -4.82% |
10 Years2016-09-30 | $ 1.12K | -99.27% |
20 Years2006-09-29 | $ 185.72K | -100.00% |
30 Years1996-09-27 | $ 772.2K | -100.00% |
All Time1995-10-13 | $ 282.15K | -100.00% |
| Period | Last Price2026-09-30 | 1 Year2025-09-30 | 5 Years2021-09-30 | 10 Years2016-09-30 | 20 Years2006-09-29 | 30 Years1996-09-27 | All Time1995-10-13 |
|---|---|---|---|---|---|---|---|
| Price | $ 8.09 | $ 3.15 | $ 8.50 | $ 1.12K | $ 185.72K | $ 772.2K | $ 282.15K |
| Return | — | 156.83% | -4.82% | -99.27% | -100.00% | -100.00% | -100.00% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 0.00 | -$ 114M | $ 187M |
| 2025 | $ 0.00 | -$ 54M | $ 36M |
| 2024 | $ 0.00 | -$ 39M | $ 34M |
| 2023 | $ 0.00 | -$ 29M | $ 15M |
| 2022 | $ 0.00 | -$ 41M | $ 24M |
| 2021 | $ 0.00 | -$ 32M | $ 43M |
| 2020 | $ 0.00 | -$ 14M | $ 35M |
| 2019 | $ 0.00 | -$ 16M | $ 16M |
| 2018 | $ 0.00 | -$ 12M | $ 14M |
| 2017 | $ 0.00 | -$ 10M | $ 5M |
| 2016 | $ 5M | -$ 20M | $ 25M |
| 2015 | $ 18M | -$ 16M | $ 55M |
| 2014 | $ 27M | -$ 26M | $ 47M |
| 2013 | $ 29M | -$ 31M | $ 39M |
| 2012 | $ 20M | -$ 21M | $ 75M |
| 2011 | $ 5M | -$ 14M | $ 64M |
| 2010 | $ 13M | -$ 12M | $ 85M |
| 2009 | $ 25M | $ 5M | $ 64M |
| 2008 | $ 20M | -$ 4M | $ 13M |
| 2007 | $ 20M | -$ 13M | $ 34M |
| 2006 | $ 22M | -$ 23M | $ 58M |
| 2005 | $ 8M | -$ 21M | $ 49M |
| 2004 | $ 264M | -$ 16M | $ 20M |
| 2003 | -$ 10M | $ 19M | |
| 2002 | -$ 11M | $ 16M | |
| 2001 | $ 8M | $ 542.18K | $ 15M |
| 2000 | $ 408.41K | -$ 2M | $ 13M |
| 1999 | $ 12M | $ 400K | $ 16M |
| 1998 | $ 5M | -$ 11M | $ 17M |
| 1997 | $ 18M | $ 1M | $ 5M |
| 1996 | $ 16M | $ 1M | $ 7M |
| IPO1995 | $ 4M | -$ 5M | $ 5M |
Achieve Life Sciences Inc fundamental performance
Between 2005 and 2025, revenue declined from $ 8M to $ 0.00 and net income went from -$ 21M to -$ 54M. Revenue increased in 4 of those 20 years; net income in 8.
Across Achieve Life Sciences Inc's full reported history, from 1995 to 2025, revenue declined from $ 4M to $ 0.00 and net income went from -$ 5M to -$ 54M. Revenue increased in 32% of the years measured; net income in 39%.
Achieve Life Sciences Inc currently holds a 20-year HDB Score of 1.5 out of 10. How the HDB Score is calculated.
Membership
Continue ACHV’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,814 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
